Leland Gershell Score: 34
Analyst at
Oppenheimer
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+24.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
56%
19 W / 15 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
65%
17 W / 9 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
12%
3 W / 23 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
4%
1 W / 25 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
59%
17 W / 12 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
56%
19 W / 15 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 01, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$312.00
Est. +20%
|
$260.25 | $272.44 |
Pending
|
$230.70
-11.4%
|
| Aug 07, 2026 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$97.00
Est. +58%
|
$61.46 | $70.98 |
Pending
|
$61.35
-0.2%
|
| Aug 03, 2026 |
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
|
BUY |
$326.00
Est. +13%
|
$287.54 | $317.49 |
Precision Hit (±3%)
|
$299.04
+4.0%
|
| Jul 16, 2026 |
UroGen Pharma Ltd
URGN
|
BUY |
$50.00
Est. +26%
|
$39.80 | $49.67 |
Bullseye Hit (±1%)
|
$41.23
+3.6%
|
| Dec 10, 2025 |
Lexeo Therapeutics Inc.
LXEO
|
BUY |
$20.00
Est. +110%
|
$9.51 | $10.99 |
Pending
|
$3.39
-64.4%
|
| Nov 12, 2025 |
enGene Holdings Inc
ENGN
|
BUY |
$33.00
Est. +248%
|
$9.47 | $12.25 |
Pending
|
$1.92
-79.7%
|
| Nov 07, 2025 |
Catalyst Pharmaceuticals Inc
CPRX
|
BUY |
$33.00
Est. +52%
|
$21.66 | $32.56 |
Precision Hit (±3%)
|
$31.49
+45.4%
|
| Nov 03, 2025 |
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
|
BUY |
$250.00
Est. +30%
|
$192.97 | $326.63 |
Target Met
|
$299.04
+55.0%
|
| Oct 31, 2025 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$500.00
Est. +11%
|
$449.56 | $479.68 |
Pending
|
$249.59
-44.5%
|
| Oct 29, 2025 |
Xeris Biopharma Holdings Inc
XERS
|
BUY |
$18.00
Est. +81%
|
$9.97 | $10.08 |
Pending
|
$8.95
-10.2%
|
| Sep 03, 2025 |
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
|
BUY |
$190.00
Est. +15%
|
$165.76 | $326.63 |
Target Met
|
$299.04
+80.4%
|
| Jul 10, 2025 |
Rhythm Pharmaceuticals Inc.
RYTM
|
BUY |
$110.00
Est. +24%
|
$89.04 | $122.20 |
Target Met
|
$98.31
+10.4%
|
| Jun 13, 2025 |
UroGen Pharma Ltd
URGN
|
BUY |
$31.00
Est. +158%
|
$12.03 | $32.37 |
Target Met
|
$41.23
+242.7%
|
| Nov 11, 2024 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$52.00
Est. +81%
|
$28.73 | $40.16 |
Miss
|
$90.71
+215.7%
|
| Oct 23, 2024 |
Xeris Biopharma Holdings Inc
XERS
|
BUY |
$5.00
Est. +66%
|
$3.02 | $9.41 |
Target Met
|
$8.95
+196.4%
|
| Oct 02, 2024 |
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
|
BUY |
$135.00
Est. +35%
|
$99.95 | $182.19 |
Target Met
|
$299.04
+199.2%
|
| Sep 17, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$190.00
Est. +32%
|
$143.90 | $208.16 |
Target Met
|
$230.70
+60.3%
|
| Sep 16, 2024 |
Essa Pharma Inc
EPIX
|
BUY |
$17.00
Est. +148%
|
$6.85 | $7.88 |
Miss
|
$0.20
-97.1%
|
| Sep 05, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$180.00
Est. +47%
|
$122.40 | $207.00 |
Target Met
|
$230.70
+88.5%
|
| Aug 27, 2024 |
Soleno Therapeutics Inc
SLNO
|
BUY |
$65.00
Est. +39%
|
$46.76 | $90.15 |
Target Met
|
$53.01
+13.4%
|
| Jul 23, 2024 |
Argen X SE - ADR
ARGX
|
BUY |
$546.00
Est. +18%
|
$461.01 | $678.21 |
Target Met
|
$962.22
+108.7%
|
| Jun 14, 2024 |
UroGen Pharma Ltd
URGN
|
BUY |
$40.00
Est. +129%
|
$17.50 | $18.15 |
Miss
|
$41.23
+135.6%
|
| Jun 04, 2024 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$74.00
Est. +60%
|
$46.28 | $62.53 |
Miss
|
$84.95
+83.6%
|
| Jun 03, 2024 |
Immunovant Inc
IMVT
|
BUY |
$46.00
Est. +81%
|
$25.39 | $34.47 |
Miss
|
$34.00
+33.9%
|
| May 14, 2024 |
UroGen Pharma Ltd
URGN
|
BUY |
$32.00
Est. +145%
|
$13.07 | $18.15 |
Miss
|
$41.23
+215.5%
|
| May 09, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$31.00
Est. +316%
|
$7.45 | $27.20 |
Miss
|
$20.66
+177.3%
|
| Apr 16, 2024 |
Avalo Therapeutics Inc
AVTX
|
BUY |
$35.00
Est. +130%
|
$15.24 | $16.00 |
Miss
|
$15.72
+3.1%
|
| Apr 15, 2024 |
Veru Inc
VERU
|
BUY |
$5.00
Est. +229%
|
$1.52 | $17.50 |
Target Met
|
$2.51
+65.1%
|
| Mar 15, 2024 |
UroGen Pharma Ltd
URGN
|
BUY |
$34.00
Est. +135%
|
$14.46 | $18.15 |
Miss
|
$41.23
+185.1%
|
| Mar 13, 2024 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$54.00
Est. +33%
|
$40.50 | $62.53 |
Target Met
|
$84.95
+109.8%
|
| Aug 31, 2023 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$40.00
Est. +129%
|
$17.43 | $55.78 |
Target Met
|
$84.95
+387.4%
|
| Apr 15, 2022 |
Veru Inc
VERU
|
BUY |
$36.00
Est. +141%
|
$14.95 | $245.50 |
Target Met
|
$2.51
-83.2%
|
| Mar 17, 2022 |
Horizon Therapeutics Plc
HZNP
|
BUY |
$140.00
Est. +32%
|
$106.39 | - | - |
$116.30
+9.3%
|
| Jun 24, 2021 |
Acceleron Pharma Inc
XLRN
|
BUY |
$160.00
Est. +29%
|
$123.93 | - | - |
$178.75
+44.2%
|
Ascendis Pharma A/S - ADR
ASND
Sep 01, 2026
Signal & Target
BUY
$312.00
Start Price
$260.25
Best Price (1Y)
$272.44
Current Price
$230.70
Return
-11.4%
Signal & Target
BUY
$97.00
Start Price
$61.46
Best Price (1Y)
$70.98
Current Price
$61.35
Return
-0.2%
Signal & Target
BUY
$326.00
Start Price
$287.54
Best Price (1Y)
$317.49
Current Price
$299.04
Return
+4.0%
UroGen Pharma Ltd
URGN
Jul 16, 2026
Signal & Target
BUY
$50.00
Start Price
$39.80
Best Price (1Y)
$49.67
Current Price
$41.23
Return
+3.6%
Lexeo Therapeutics Inc.
LXEO
Dec 10, 2025
Signal & Target
BUY
$20.00
Start Price
$9.51
Best Price (1Y)
$10.99
Current Price
$3.39
Return
-64.4%
enGene Holdings Inc
ENGN
Nov 12, 2025
Signal & Target
BUY
$33.00
Start Price
$9.47
Best Price (1Y)
$12.25
Current Price
$1.92
Return
-79.7%
Catalyst Pharmaceuticals Inc
CPRX
Nov 07, 2025
Signal & Target
BUY
$33.00
Start Price
$21.66
Best Price (1Y)
$32.56
Current Price
$31.49
Return
+45.4%
Signal & Target
BUY
$250.00
Start Price
$192.97
Best Price (1Y)
$326.63
Current Price
$299.04
Return
+55.0%
Alnylam Pharmaceuticals Inc
ALNY
Oct 31, 2025
Signal & Target
BUY
$500.00
Start Price
$449.56
Best Price (1Y)
$479.68
Current Price
$249.59
Return
-44.5%
Xeris Biopharma Holdings Inc
XERS
Oct 29, 2025
Signal & Target
BUY
$18.00
Start Price
$9.97
Best Price (1Y)
$10.08
Current Price
$8.95
Return
-10.2%
Signal & Target
BUY
$190.00
Start Price
$165.76
Best Price (1Y)
$326.63
Current Price
$299.04
Return
+80.4%
Rhythm Pharmaceuticals Inc.
RYTM
Jul 10, 2025
Signal & Target
BUY
$110.00
Start Price
$89.04
Best Price (1Y)
$122.20
Current Price
$98.31
Return
+10.4%
UroGen Pharma Ltd
URGN
Jun 13, 2025
Signal & Target
BUY
$31.00
Start Price
$12.03
Best Price (1Y)
$32.37
Current Price
$41.23
Return
+242.7%
Dianthus Therapeutics Inc
DNTH
Nov 11, 2024
Signal & Target
BUY
$52.00
Start Price
$28.73
Best Price (1Y)
$40.16
Current Price
$90.71
Return
+215.7%
Xeris Biopharma Holdings Inc
XERS
Oct 23, 2024
Signal & Target
BUY
$5.00
Start Price
$3.02
Best Price (1Y)
$9.41
Current Price
$8.95
Return
+196.4%
Signal & Target
BUY
$135.00
Start Price
$99.95
Best Price (1Y)
$182.19
Current Price
$299.04
Return
+199.2%
Ascendis Pharma A/S - ADR
ASND
Sep 17, 2024
Signal & Target
BUY
$190.00
Start Price
$143.90
Best Price (1Y)
$208.16
Current Price
$230.70
Return
+60.3%
Essa Pharma Inc
EPIX
Sep 16, 2024
Signal & Target
BUY
$17.00
Start Price
$6.85
Best Price (1Y)
$7.88
Current Price
$0.20
Return
-97.1%
Ascendis Pharma A/S - ADR
ASND
Sep 05, 2024
Signal & Target
BUY
$180.00
Start Price
$122.40
Best Price (1Y)
$207.00
Current Price
$230.70
Return
+88.5%
Soleno Therapeutics Inc
SLNO
Aug 27, 2024
Signal & Target
BUY
$65.00
Start Price
$46.76
Best Price (1Y)
$90.15
Current Price
$53.01
Return
+13.4%
Argen X SE - ADR
ARGX
Jul 23, 2024
Signal & Target
BUY
$546.00
Start Price
$461.01
Best Price (1Y)
$678.21
Current Price
$962.22
Return
+108.7%
UroGen Pharma Ltd
URGN
Jun 14, 2024
Signal & Target
BUY
$40.00
Start Price
$17.50
Best Price (1Y)
$18.15
Current Price
$41.23
Return
+135.6%
Crinetics Pharmaceuticals Inc
CRNX
Jun 04, 2024
Signal & Target
BUY
$74.00
Start Price
$46.28
Best Price (1Y)
$62.53
Current Price
$84.95
Return
+83.6%
Immunovant Inc
IMVT
Jun 03, 2024
Signal & Target
BUY
$46.00
Start Price
$25.39
Best Price (1Y)
$34.47
Current Price
$34.00
Return
+33.9%
UroGen Pharma Ltd
URGN
May 14, 2024
Signal & Target
BUY
$32.00
Start Price
$13.07
Best Price (1Y)
$18.15
Current Price
$41.23
Return
+215.5%
Viridian Therapeutics Inc
VRDN
May 09, 2024
Signal & Target
BUY
$31.00
Start Price
$7.45
Best Price (1Y)
$27.20
Current Price
$20.66
Return
+177.3%
Avalo Therapeutics Inc
AVTX
Apr 16, 2024
Signal & Target
BUY
$35.00
Start Price
$15.24
Best Price (1Y)
$16.00
Current Price
$15.72
Return
+3.1%
Veru Inc
VERU
Apr 15, 2024
Signal & Target
BUY
$5.00
Start Price
$1.52
Best Price (1Y)
$17.50
Current Price
$2.51
Return
+65.1%
UroGen Pharma Ltd
URGN
Mar 15, 2024
Signal & Target
BUY
$34.00
Start Price
$14.46
Best Price (1Y)
$18.15
Current Price
$41.23
Return
+185.1%
Crinetics Pharmaceuticals Inc
CRNX
Mar 13, 2024
Signal & Target
BUY
$54.00
Start Price
$40.50
Best Price (1Y)
$62.53
Current Price
$84.95
Return
+109.8%
Crinetics Pharmaceuticals Inc
CRNX
Aug 31, 2023
Signal & Target
BUY
$40.00
Start Price
$17.43
Best Price (1Y)
$55.78
Current Price
$84.95
Return
+387.4%
Veru Inc
VERU
Apr 15, 2022
Signal & Target
BUY
$36.00
Start Price
$14.95
Best Price (1Y)
$245.50
Current Price
$2.51
Return
-83.2%
Horizon Therapeutics Plc
HZNP
Mar 17, 2022
Signal & Target
BUY
$140.00
Start Price
$106.39
Best Price (1Y)
-
Current Price
$116.30
Return
+9.3%
Acceleron Pharma Inc
XLRN
Jun 24, 2021
Signal & Target
BUY
$160.00
Start Price
$123.93
Best Price (1Y)
-
Current Price
$178.75
Return
+44.2%